Equities research analysts forecast that Synopsys, Inc. (NASDAQ:SNPS) will report sales of $751.36 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Synopsys’ earnings, with the lowest sales estimate coming in at $743.00 million and the highest estimate coming in at $757.90 million. Synopsys posted sales of $652.79 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 15.1%. The business is expected to report its next earnings report after the market closes on Wednesday, February 21st.

On average, analysts expect that Synopsys will report full year sales of $751.36 million for the current year, with estimates ranging from $2.90 billion to $2.91 billion. For the next financial year, analysts expect that the company will report sales of $3.08 billion per share, with estimates ranging from $3.05 billion to $3.11 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Synopsys.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, November 29th. The semiconductor company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.12. The firm had revenue of $696.60 million for the quarter, compared to analysts’ expectations of $650.72 million. Synopsys had a net margin of 5.01% and a return on equity of 5.78%. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.77 earnings per share.

Several analysts recently issued reports on the stock. BidaskClub cut shares of Synopsys from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. DA Davidson reaffirmed a “buy” rating and issued a $105.00 price target (up from $91.00) on shares of Synopsys in a report on Tuesday, November 28th. Needham & Company LLC upped their price target on shares of Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, November 30th. TheStreet cut shares of Synopsys from an “a” rating to a “c+” rating in a report on Wednesday, November 29th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $106.00 price target (up from $86.00) on shares of Synopsys in a report on Thursday, November 30th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. Synopsys currently has a consensus rating of “Hold” and an average target price of $96.89.

Synopsys (SNPS) traded up $1.72 on Friday, reaching $84.34. 1,718,700 shares of the company traded hands, compared to its average volume of 985,687. The firm has a market capitalization of $12,542.51, a PE ratio of 100.48, a PEG ratio of 3.76 and a beta of 1.04. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.04. Synopsys has a 1 year low of $65.31 and a 1 year high of $94.80.

In other Synopsys news, Director Chrysostomos L. Nikias sold 21,074 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $89.78, for a total transaction of $1,892,023.72. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Chi-Foon Chan sold 3,750 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $89.78, for a total transaction of $336,675.00. The disclosure for this sale can be found here. Insiders have sold 65,442 shares of company stock worth $5,779,693 over the last three months. 1.82% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of the business. Advisor Group Inc. grew its position in shares of Synopsys by 14.3% during the second quarter. Advisor Group Inc. now owns 2,617 shares of the semiconductor company’s stock worth $190,000 after acquiring an additional 327 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its position in shares of Synopsys by 8.0% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 9,298 shares of the semiconductor company’s stock worth $749,000 after acquiring an additional 690 shares during the last quarter. National Pension Service grew its position in shares of Synopsys by 0.4% during the fourth quarter. National Pension Service now owns 176,640 shares of the semiconductor company’s stock worth $15,057,000 after acquiring an additional 692 shares during the last quarter. GHP Investment Advisors Inc. grew its position in shares of Synopsys by 2.2% during the third quarter. GHP Investment Advisors Inc. now owns 32,385 shares of the semiconductor company’s stock worth $2,608,000 after acquiring an additional 695 shares during the last quarter. Finally, Strs Ohio grew its position in shares of Synopsys by 3.8% during the third quarter. Strs Ohio now owns 20,004 shares of the semiconductor company’s stock worth $1,610,000 after acquiring an additional 729 shares during the last quarter. 89.77% of the stock is currently owned by institutional investors.

WARNING: This report was originally posted by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.dailypolitical.com/2018/02/12/synopsys-inc-snps-expected-to-post-quarterly-sales-of-751-36-million-2.html.

About Synopsys

Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.

Get a free copy of the Zacks research report on Synopsys (SNPS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.